Medtronic plc (0Y6X.L)
USD 83.89
(1.44%)
USD 83.89
(1.44%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 32.36 Billion USD | 3.64% |
| 2022 | 31.22 Billion USD | -1.45% |
| 2021 | 31.68 Billion USD | 5.21% |
| 2020 | 30.11 Billion USD | 4.16% |
| 2019 | 28.91 Billion USD | -5.38% |
| 2018 | 30.55 Billion USD | 2.02% |
| 2017 | 29.95 Billion USD | 0.82% |
| 2016 | 29.71 Billion USD | 3.04% |
| 2015 | 28.83 Billion USD | 42.31% |
| 2014 | 20.26 Billion USD | 19.94% |
| 2013 | 16.89 Billion USD | 1.96% |
| 2012 | 16.56 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 7.91 Billion USD | -7.85% |
| 2023 Q1 | 7.7 Billion USD | -9.85% |
| 2023 Q2 | 7.98 Billion USD | 3.66% |
| 2023 Q3 | 8.08 Billion USD | 1.32% |
| 2023 Q4 | 8.58 Billion USD | 6.18% |
| 2023 FY | 32.36 Billion USD | 3.64% |
| 2022 Q3 | 7.72 Billion USD | 1.87% |
| 2022 Q4 | 8.54 Billion USD | 10.57% |
| 2022 Q1 | 7.37 Billion USD | -8.88% |
| 2022 Q2 | 7.58 Billion USD | 2.9% |
| 2022 FY | 31.22 Billion USD | -1.45% |
| 2021 Q1 | 7.98 Billion USD | -2.45% |
| 2021 FY | 31.68 Billion USD | 5.21% |
| 2021 Q2 | 7.84 Billion USD | -1.75% |
| 2021 Q3 | 7.76 Billion USD | -1.07% |
| 2021 Q4 | 8.08 Billion USD | 4.2% |
| 2020 Q2 | 7.64 Billion USD | 17.52% |
| 2020 FY | 30.11 Billion USD | 4.16% |
| 2020 Q1 | 6.5 Billion USD | 8.5% |
| 2020 Q3 | 7.77 Billion USD | 1.67% |
| 2020 Q4 | 8.18 Billion USD | 5.31% |
| 2019 Q2 | 7.7 Billion USD | 2.84% |
| 2019 FY | 28.91 Billion USD | -5.38% |
| 2019 Q4 | 5.99 Billion USD | -22.29% |
| 2019 Q3 | 7.71 Billion USD | 0.14% |
| 2019 Q1 | 7.49 Billion USD | -8.02% |
| 2018 Q2 | 7.48 Billion USD | 1.31% |
| 2018 Q4 | 8.14 Billion USD | 7.95% |
| 2018 Q3 | 7.54 Billion USD | 0.87% |
| 2018 Q1 | 7.38 Billion USD | -9.33% |
| 2018 FY | 30.55 Billion USD | 2.02% |
| 2017 Q1 | 7.39 Billion USD | -6.64% |
| 2017 FY | 29.95 Billion USD | 0.82% |
| 2017 Q3 | 7.36 Billion USD | 4.52% |
| 2017 Q4 | 8.14 Billion USD | 10.52% |
| 2017 Q2 | 7.05 Billion USD | -4.6% |
| 2016 Q1 | 7.16 Billion USD | -5.3% |
| 2016 FY | 29.71 Billion USD | 3.04% |
| 2016 Q4 | 7.91 Billion USD | 8.69% |
| 2016 Q3 | 7.28 Billion USD | -0.84% |
| 2016 Q2 | 7.34 Billion USD | 2.5% |
| 2015 Q3 | 6.93 Billion USD | -1.76% |
| 2015 FY | 28.83 Billion USD | 42.31% |
| 2015 Q1 | 7.27 Billion USD | 1.46% |
| 2015 Q2 | 7.05 Billion USD | -2.97% |
| 2015 Q4 | 7.56 Billion USD | 9.13% |
| 2014 Q2 | 4.36 Billion USD | 2.18% |
| 2014 FY | 20.26 Billion USD | 19.94% |
| 2014 Q4 | 7.16 Billion USD | 66.03% |
| 2014 Q3 | 4.31 Billion USD | -1.1% |
| 2014 Q1 | 4.27 Billion USD | -4.04% |
| 2013 Q4 | 4.45 Billion USD | 6.97% |
| 2013 Q2 | 4.19 Billion USD | 2.72% |
| 2013 Q1 | 4.08 Billion USD | -8.02% |
| 2013 Q3 | 4.16 Billion USD | -0.74% |
| 2013 FY | 16.89 Billion USD | 1.96% |
| 2012 Q4 | 4.43 Billion USD | 10.23% |
| 2012 FY | 16.56 Billion USD | 0.0% |
| 2012 Q3 | 4.02 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -8983.382% |
| Accuray Incorporated | 446.55 Million USD | -7147.548% |
| Align Technology, Inc. | 3.86 Billion USD | -737.955% |
| Elevance Health Inc. | 171.34 Billion USD | 81.111% |
| AxoGen, Inc. | 159.01 Million USD | -20253.181% |
| Boston Scientific Corporation | 14.24 Billion USD | -127.275% |
| CVS Health Corporation | 357.77 Billion USD | 90.954% |
| Cardinal Health, Inc. | 226.82 Billion USD | 85.732% |
| Centene Corporation | 141.26 Billion USD | 77.09% |
| DaVita Inc. | 12.14 Billion USD | -166.587% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 50.185% |
| Hologic, Inc. | 4.03 Billion USD | -703.017% |
| Humana Inc. | 106.37 Billion USD | 69.575% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -784.032% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -166.116% |
| Masimo Corporation | 2.04 Billion USD | -1480.196% |
| McKesson Corporation | 308.95 Billion USD | 89.525% |
| Patterson Companies, Inc. | 6.56 Billion USD | -392.732% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -249.805% |
| ResMed Inc. | 4.68 Billion USD | -590.757% |
| Henry Schein, Inc. | 12.33 Billion USD | -162.29% |
| Teladoc Health, Inc. | 2.6 Billion USD | -1143.614% |
| Universal Health Services, Inc. | 14.28 Billion USD | -126.607% |
| Veeva Systems Inc. | 2.36 Billion USD | -1269.225% |
| Baxter International Inc. | 14.81 Billion USD | -118.484% |
| Becton, Dickinson and Company | 19.37 Billion USD | -67.066% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -354.289% |
| Danaher Corporation | 23.89 Billion USD | -35.471% |
| Stryker Corporation | 20.49 Billion USD | -57.889% |